Readership
Caregivers, Clinical Pharmacists, Clinical Pharmacologists, Clinical Researchers, Clinicians, Formulary Managers, Health Professionals, Health Scientists, Health Service Researchers, Health Technology Assessment (HTA) Professionals, Healthcare Executives, Ophthalmologists, Patients, Pharmaceutical Benefits Managers, Pharmaceutical Scientistists, Pharmacists, Pharmacologists, Physicians, Physicians - Medicine, Researchers, Residents
Scope
Ophthalmology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad and will consider all scientifically sound research from preclinical, clinical (all phases), observational, real-world, and health outcomes research around the use of ophthalmological therapies, devices, and surgical techniques.
The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/series, trial protocols and short communications such as commentaries and editorials. Ophthalmology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals.